Patients are now being recruited for the world’s first personalised genomics-driven ovarian cancer vaccine clinical trial. The goal is to prevent an often deadly relapse of the disease in women diagnosed at advanced stages. The injectable vaccine OncoImmunome works by boosting the patient’s immune response to enable it to destroy ovarian cancer cells should they…
A bereaved husband has put out an appeal to women to visit their GP if they display any symptoms of ovarian cancer after the devastating illness claimed the life of his wife. Angie Morgan, who was a property conveyancer at Stamford law firm, Chattertons Solicitors and Wealth Management, died aged 65 in 2015, after her…
The results of the UK Familial Ovarian Cancer Screening Study, which is led by the UCL, show that screening women at high risk of ovarian cancer every four months may reduce the risk of them being diagnosed with advanced cancer. It remains uncertain whether detecting ovarian cancer by screening increases the chances of a woman…
The US Food and Drug Administration (FDA) warns that it does not recommend the use of any currently available ovarian cancer screening tests to detect the disease. The FDA cautions that such screening tests are unreliable and may generate false-positive (suggesting the presence of cancer when it is not there) or false-negative results (indicating absence…
Cancers that start in a woman’s reproductive system are called gynaecological cancers. Treatment for each cancer depends on when and where the cancer started. Early detection is vital for increased survival, so knowing the symptoms and making sure to make a doctor’s appointment is key. Unfortunately, girls and women become somewhat used to cramps and pains in their uterus…
